Small molecule inhibitor of OGG1 blocks oxidative DNA damage repair at telomeres and potentiates methotrexate anticancer effects

Sci Rep. 2021 Feb 10;11(1):3490. doi: 10.1038/s41598-021-82917-7.

Abstract

The most common oxidative DNA lesion is 8-oxoguanine which is mainly recognized and excised by the 8-oxoG DNA glycosylase 1 (OGG1), initiating the base excision repair (BER) pathway. Telomeres are particularly sensitive to oxidative stress (OS) which disrupts telomere homeostasis triggering genome instability. In the present study, we have investigated the effects of inactivating BER in OS conditions, by using a specific inhibitor of OGG1 (TH5487). We have found that in OS conditions, TH5487 blocks BER initiation at telomeres causing an accumulation of oxidized bases, that is correlated with telomere losses, micronuclei formation and mild proliferation defects. Moreover, the antimetabolite methotrexate synergizes with TH5487 through induction of intracellular reactive oxygen species (ROS) formation, which potentiates TH5487-mediated telomere and genome instability. Our findings demonstrate that OGG1 is required to protect telomeres from OS and present OGG1 inhibitors as a tool to induce oxidative DNA damage at telomeres, with the potential for developing new combination therapies for cancer treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology*
  • Benzimidazoles / pharmacology*
  • Cell Cycle
  • Cell Line, Tumor
  • DNA Glycosylases / antagonists & inhibitors*
  • DNA Glycosylases / metabolism
  • DNA Repair / drug effects*
  • Drug Synergism
  • Enzyme Inhibitors / pharmacology
  • Genomic Instability
  • Humans
  • Methotrexate / pharmacology*
  • Oxidation-Reduction
  • Oxidative Stress*
  • Piperidines / pharmacology*
  • Reactive Oxygen Species / metabolism
  • Telomere / metabolism*

Substances

  • Antimetabolites, Antineoplastic
  • Benzimidazoles
  • Enzyme Inhibitors
  • Piperidines
  • Reactive Oxygen Species
  • TH5487
  • DNA Glycosylases
  • Methotrexate